Sbi Securities Co., Ltd. Aclaris Therapeutics, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 66 shares of ACRS stock, worth $169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66Holding current value
$169% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACRS
# of Institutions
80Shares Held
48.8MCall Options Held
30.6KPut Options Held
1K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$36.6 Million9.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.69MShares$12 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.37MShares$8.67 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.01MShares$7.72 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.75MShares$7.08 Million0.11% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $171M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...